Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
https://www.nejm.org/doi/pdf/10.1056/NEJMoa2306441
0
0
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions | NEJM - nejm.org
10/21/23 at 2:30pm
Organization
nejm.org
Author
nejm.org
Details
13 words
Summarize
Business & Industrial
Amivantamab
NSCLC
EGFR Exon 20 Insertions
Show more
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...